Breast cancer (BC) is the most common malignancy among women, and the second cause of cancer-related mortality worldwide.1 Up to 20% of BCs harbor overexpression of Human Epidermal growth factor Receptor 2 (HER2) protein and/or amplification of the HER2 gene. This evidence concerns the gene ERBB2 and cancer.